Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
SecondOpinionExpert
AddedFeb 16, 2024
UpdatedJun 18, 2026
SecondOpinionExpert

SecondOpinionExpert

SecondOpinionExpert offers timely, cost-efficient expert medical second opinions.

HQ
Dana Point, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

SecondOpinionExpert, founded with the mission to provide timely, effective, and cost-efficient expert medical second opinions, focuses on enhancing patient care through advanced telemedicine solutions. Their core services include XperTeleConsult™, which simplifies obtaining medical opinions, and XperTeleRadiology™, offering real-time cardio monitoring. They also provide Independent Medical Evaluations for insurance claims and a customizable Software as a Service platform. The company aims to bring care, dignity, and compassion to patients and their families, particularly in post-acute nursing care.

Notable affiliated individuals and investors have not been specified, but the company has achieved significant milestones in telemedicine by integrating state-of-the-art technology into their services. Their impact is evident in the relief provided to patients and families through accessible expert medical opinions and long-term care solutions. SecondOpinionExpert continues to innovate in the healthcare sector, ensuring that patients receive accurate and timely medical advice, thereby improving overall healthcare outcomes.

SecondOpinionExpert - Similar Companies

First Opinion logo

First Opinion

Bicmd logo

Bicmd

bicmd.com

TeleMedicX logo

TeleMedicX

telemedicx.com

DrAvailable logo

DrAvailable

BabyLiveAdvice logo

BabyLiveAdvice

babyliveadvice.com

EZaccessMD logo

EZaccessMD

ezaccessmd.com

eVisit logo

eVisit

evisit.com

Medplace logo

Medplace

medplace.com

MyTelemedicine logo

MyTelemedicine

mytelemedicine.com

CallingDr logo

CallingDr

Text2MD logo

Text2MD

text2md.com

HeyDoc! logo

HeyDoc!

heydoc.net

Akos MD logo

Akos MD

akosmd.com

HealthTap logo

HealthTap

Teladoc logo

Teladoc

teladochealth.com

SecondOpinionExpert - Quick Facts

Who are SecondOpinionExpert's competitors?

Companies similar to SecondOpinionExpert include First Opinion, Bicmd, TeleMedicX and DrAvailable.

When was SecondOpinionExpert founded?

SecondOpinionExpert was founded in 2014.

Where is SecondOpinionExpert's headquarters located?

SecondOpinionExpert's headquarters is located in Dana Point, CA, US.

When was SecondOpinionExpert's last funding round?

SecondOpinionExpert's most recent funding round was for $750k (USD) in June 2014.

How much has SecondOpinionExpert raised to-date?

As of Jun 11, 2014, SecondOpinionExpert has raised a total of $750k (USD).

How many employees does SecondOpinionExpert have?

SecondOpinionExpert has 14 employees as of Feb 5, 2024.

SecondOpinionExpert - Classification

Ownership
  • Private
Technology
  • Telemedicine
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
  • Enterprise
Main Product
  • Medical Second Opinions
  • Telemedicine
Tags
  • Healthtech
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations